-
Exact Sciences Shares Higher After Q3 Beat And Raise
Tuesday, October 31, 2017 - 11:09am | 341Read More...Analysts at Bank of America turned incrementally bullish on EXACT Sciences Corporation (NASDAQ: EXAS) after the company reported a clean beat and raise quarter. The firm's Anne Edelstein maintains a Buy rating on Exact Sciences' stock with a price target boosted from $56 to $58. Exact Sciences'...
-
In Its Best Year Since Going Public, Q4 A Catalyst For Catalent
Tuesday, August 29, 2017 - 11:44am | 600Read More...Reviewing the fiscal year fourth-quarter results of Catalent Inc (NYSE: CTLT), the sell side exuded optimism concerning the company. Bank of America Merrill Lynch said the company has had a strong finish to its best year since IPOing, while Wells Fargo Securities said momentum at the company...
-
Risk-Reward Still Suggests Exact Sciences Is A Buy, But Be Cautious
Wednesday, July 26, 2017 - 2:01pm | 357Read More...Following EXACT Sciences Corporation (NASDAQ: EXAS)'s beat-and-raise quarter, Bank of America Merrill Lynch said risk/reward still suggests the stock is a Buy, although suggesting to proceed with caution due to valuation. Analysts Anne Edelstein, Derik de Bruin, Michael Ryskin and Juan Avendano...
